{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:11:53Z","timestamp":1787065913763,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvascsurg.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Surgery"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.jvs.2018.05.239","type":"journal-article","created":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T20:35:23Z","timestamp":1538598923000},"page":"190-198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Metabolic syndrome is associated with increased cardiac morbidity after infrainguinal bypass surgery irrespective of the use of cardiovascular risk-modifying agents"],"prefix":"10.1016","volume":"69","author":[{"given":"Rebecca","family":"Sorber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Lehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Husain N.","family":"Alshaikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Abularrage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"James H.","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying Wei","family":"Lum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvs.2018.05.239_bib1","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1001\/jama.2015.4260","article-title":"Prevalence of the metabolic syndrome in the United States, 2003-2012","volume":"313","author":"Aguilar","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jvs.2018.05.239_bib2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1242\/dmm.001180","article-title":"A\u00a0comprehensive definition for metabolic syndrome","volume":"2","author":"Huang","year":"2009","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.jvs.2018.05.239_bib3","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1089\/met.2009.0059","article-title":"Metabolic syndrome and angiographic coronary artery disease prevalence in association with the Framingham risk score","volume":"8","author":"Konstantinou","year":"2010","journal-title":"Metab Syndr Relat Disord"},{"key":"10.1016\/j.jvs.2018.05.239_bib4","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.7754\/Clin.Lab.2015.150219","article-title":"Metabolic syndrome, independent predictor for coronary artery disease","volume":"61","author":"Zidi","year":"2015","journal-title":"Clin Lab"},{"key":"10.1016\/j.jvs.2018.05.239_bib5","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2174\/157016108785909760","article-title":"Resistance to aspirin and thienopyridines in diabetes mellitus and metabolic syndrome","volume":"6","author":"Anfossi","year":"2008","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.jvs.2018.05.239_bib6","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.athoracsur.2016.10.021","article-title":"Angiotensin receptor blockade improves cardiac surgical outcomes in patients with metabolic syndrome","volume":"104","author":"Manning","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jvs.2018.05.239_bib7","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.atherosclerosis.2003.12.033","article-title":"Prevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm","volume":"173","author":"Gorter","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jvs.2018.05.239_bib8","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.avsg.2013.10.015","article-title":"Metabolic syndrome reduces the survival benefit of the obesity paradox after infrainguinal bypass","volume":"28","author":"Arnaoutakis","year":"2014","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jvs.2018.05.239_bib9","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/j.arth.2012.04.011","article-title":"The metabolic syndrome in patients undergoing knee and hip arthroplasty: trends and in-hospital outcomes in the United States","volume":"27","author":"Gonzalez Della Valle","year":"2012","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.jvs.2018.05.239_bib10","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.amjsurg.2017.02.018","article-title":"The impact of metabolic syndrome and its components on perioperative outcomes after elective laparotomy\u2014a prospective observational study","volume":"214","author":"Laou","year":"2017","journal-title":"Am J Surg"},{"key":"10.1016\/j.jvs.2018.05.239_bib11","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.jvs.2013.10.081","article-title":"Metabolic syndrome is associated with type II endoleak after endovascular abdominal aortic aneurysm repair","volume":"59","author":"Hall","year":"2014","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2018.05.239_bib12","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jvs.2011.10.109","article-title":"Impact of metabolic syndrome on the outcomes of superficial femoral artery interventions","volume":"55","author":"Smolock","year":"2012","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2018.05.239_bib13","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.atherosclerosis.2009.12.018","article-title":"Metabolic syndrome is an independent predictor of cardiovascular events in high-risk patients with occlusive and aneurysmatic peripheral arterial disease","volume":"210","author":"van Kuijk","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jvs.2018.05.239_bib14","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jamcollsurg.2014.04.014","article-title":"Metabolic syndrome predicts restenosis after carotid endarterectomy","volume":"219","author":"Williams","year":"2014","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.jvs.2018.05.239_bib15","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.avsg.2017.08.011","article-title":"Metabolic syndrome but not obesity adversely affects outcomes after open aortoiliac bypass surgery","volume":"46","author":"Tanaka","year":"2018","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jvs.2018.05.239_bib16","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jamcollsurg.2013.02.027","article-title":"Optimizing ACS NSQIP modeling for evaluation of surgical quality and risk: patient risk adjustment, procedure mix adjustment, shrinkage adjustment, and surgical focus","volume":"217","author":"Cohen","year":"2013","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.jvs.2018.05.239_bib17","series-title":"American College of Surgeons National Surgical Quality Improvement Program. User guide for the 2014 ACS-NSQIP Participant Use Data File (PUF)","year":"2015"},{"key":"10.1016\/j.jvs.2018.05.239_bib18","first-page":"744","article-title":"Modified metabolic syndrome criteria for identification of patients at risk of diabetes and coronary heart diseases: longitudinal assessment via electronic health records","volume":"28","author":"Hivert","year":"2012","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jvs.2018.05.239_bib19","first-page":"e0006082","article-title":"Body mass index is associated with microvascular endothelial dysfunction in patients with treated metabolic risk factors and suspected coronary artery disease","volume":"6","author":"van der Heijden","year":"2017","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jvs.2018.05.239_bib20","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.jvs.2008.12.011","article-title":"Metabolic syndrome: a predictor of adverse outcomes after carotid revascularization","volume":"49","author":"Protack","year":"2009","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2018.05.239_bib21","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/ALN.0b013e3181eff32e","article-title":"Perioperative outcomes among patients with the modified metabolic syndrome who are undergoing noncardiac surgery","volume":"113","author":"Glance","year":"2010","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jvs.2018.05.239_bib22","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.jvs.2012.04.011","article-title":"The impact of diabetes on postoperative outcomes following lower extremity bypass surgery","volume":"56","author":"Wallaert","year":"2012","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2018.05.239_bib23","first-page":"e169","volume":"120","author":"Fleisher","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2018.05.239_bib24","series-title":"Rutherford's vascular surgery","first-page":"1758","article-title":"Infrainguinal disease: surgical treatment","author":"Mills","year":"2014"},{"key":"10.1016\/j.jvs.2018.05.239_bib25","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1136\/heartjnl-2013-304262","article-title":"Meta-analysis of secure randomised controlled trials of beta-blockade to prevent perioperative death in non-cardiac surgery","volume":"100","author":"Bouri","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.jvs.2018.05.239_bib26","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.amjmed.2012.03.014","article-title":"Perioperative mischief: the price of academic misconduct","volume":"125","author":"Chopra","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.jvs.2018.05.239_bib27","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/S0140-6736(08)61560-3","article-title":"Perioperative beta blockers in patients having non-cardiac surgery: a meta-analysis","volume":"372","author":"Bangalore","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jvs.2018.05.239_bib28","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.jvs.2010.10.131","article-title":"A\u00a0regional quality improvement effort to increase beta blocker administration before vascular surgery","volume":"53","author":"Goodney","year":"2011","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2018.05.239_bib29","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jvs.2015.01.053","article-title":"Preoperative beta-blockers do not improve cardiac outcomes after major elective vascular surgery and may be harmful","volume":"62","author":"Scali","year":"2015","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2018.05.239_bib30","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jvs.2006.02.048","article-title":"Metabolic syndrome in peripheral arterial disease: relationship with severity of peripheral circulatory insufficiency, inflammatory status, and cardiovascular comorbidity","volume":"44","author":"Brevetti","year":"2006","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2018.05.239_bib31","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12944-015-0075-5","article-title":"Influence of metabolic syndrome factors and insulin resistance on the efficacy of ezetimibe\/simvastatin and atorvastatin in patients with metabolic syndrome and atherosclerotic coronary heart disease risk","volume":"4","author":"Rosen","year":"2015","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.jvs.2018.05.239_bib32","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.metabol.2013.11.006","article-title":"Effect of renin-angiotensin system inhibition on cardiovascular events in older hypertensive patients with metabolic syndrome","volume":"63","author":"Zreikat","year":"2014","journal-title":"Metabolism"},{"key":"10.1016\/j.jvs.2018.05.239_bib33","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.jvs.2006.06.035","article-title":"The effects of the type of anesthesia on outcomes of lower extremity infrainguinal bypass","volume":"44","author":"Singh","year":"2006","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2018.05.239_bib34","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10016-004-0136-0","article-title":"Tibial angioplasty as an alternative strategy in patients with limb threatening ischemia","volume":"19","author":"Clair","year":"2005","journal-title":"Ann Vasc Surg"}],"container-title":["Journal of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521418316574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521418316574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T20:18:37Z","timestamp":1760041117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0741521418316574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0741521418316574"],"URL":"https:\/\/doi.org\/10.1016\/j.jvs.2018.05.239","relation":{},"ISSN":["0741-5214"],"issn-type":[{"value":"0741-5214","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic syndrome is associated with increased cardiac morbidity after infrainguinal bypass surgery irrespective of the use of cardiovascular risk-modifying agents","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvs.2018.05.239","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the Society for Vascular Surgery. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}